These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 23278838

  • 1. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.
    Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
    [Abstract] [Full Text] [Related]

  • 2. Clinical features of atypical Kawasaki disease.
    Hsieh YC, Wu MH, Wang JK, Lee PI, Lee CY, Huang LM.
    J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122
    [Abstract] [Full Text] [Related]

  • 3. Atypical and complicated Kawasaki disease in infants. Do we need criteria?
    Joffe A, Kabani A, Jadavji T.
    West J Med; 1995 Apr; 162(4):322-7. PubMed ID: 7747497
    [Abstract] [Full Text] [Related]

  • 4. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [Abstract] [Full Text] [Related]

  • 5. Kawasaki disease in older children and adolescents.
    Stockheim JA, Innocentini N, Shulman ST.
    J Pediatr; 2000 Aug; 137(2):250-2. PubMed ID: 10931420
    [Abstract] [Full Text] [Related]

  • 6. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
    Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
    [Abstract] [Full Text] [Related]

  • 8. Kawasaki disease in central area of Northeast Thailand.
    Panamonta M, Chaikitpinyo A, Durongpisitkul K, Somchit S, Petcharatana S, Wongswadiwat Y, Kosalaraksa P, Lumbiganon P.
    J Med Assoc Thai; 2004 Aug; 87(8):887-90. PubMed ID: 15471291
    [Abstract] [Full Text] [Related]

  • 9. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
    Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
    Pediatr Infect Dis J; 2004 Jan; 23(1):52-5. PubMed ID: 14743047
    [Abstract] [Full Text] [Related]

  • 10. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N, Heaton P, Calder L, Nicholson R, Stables S, Gavin R.
    J Paediatr Child Health; 2004 Jan; 40(9-10):524-9. PubMed ID: 15367145
    [Abstract] [Full Text] [Related]

  • 11. Kawasaki disease in Thai infants compared with older children.
    Sittiwangkul R, Pongprot Y, Thongsongkrit W, Silvilairat S, Phornphutkul C.
    Ann Trop Paediatr; 2004 Mar; 24(1):59-63. PubMed ID: 15005968
    [Abstract] [Full Text] [Related]

  • 12. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
    Pediatr Cardiol; 2003 Dec; 24(2):122-6. PubMed ID: 12457252
    [Abstract] [Full Text] [Related]

  • 14. Clinical spectrum of Kawasaki disease in infants.
    Tseng CF, Fu YC, Fu LS, Betau H, Chi CS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):168-73. PubMed ID: 11458622
    [Abstract] [Full Text] [Related]

  • 15. Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions.
    Chbeir D, Gaschignard J, Bonnefoy R, Beyler C, Melki I, Faye A, Meinzer U.
    Pediatr Rheumatol Online J; 2018 Jul 18; 16(1):48. PubMed ID: 30021610
    [Abstract] [Full Text] [Related]

  • 16. Kawasaki disease in infants less than one year of age.
    Rosenfeld EA, Corydon KE, Shulman ST.
    J Pediatr; 1995 Apr 18; 126(4):524-9. PubMed ID: 7699529
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology, etiology, and management of Kawasaki disease: state of the art.
    Laupland KB, Dele Davies H.
    Pediatr Cardiol; 1999 Apr 18; 20(3):177-83. PubMed ID: 10089240
    [Abstract] [Full Text] [Related]

  • 18. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease.
    Cameron SA, Carr M, Pahl E, DeMarais N, Shulman ST, Rowley AH.
    Arch Dis Child; 2019 May 18; 104(5):451-455. PubMed ID: 30413485
    [Abstract] [Full Text] [Related]

  • 19. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome.
    Saulsbury FT.
    Clin Pediatr (Phila); 2002 Oct 18; 41(8):597-601. PubMed ID: 12403377
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
    Hsu CH, Chen MR, Hwang FY, Kao HA, Hung HY, Hsu CH.
    Pediatr Infect Dis J; 1993 Jun 18; 12(6):509-12. PubMed ID: 8345983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.